A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added two more [...] …
Category: Pharma Industry
340B Health System’s Suit Against Drugmakers Seeks to Recover ‘Hundreds of Millions in Overpayments’
A California health system is continuing a previously sealed whistleblower case it first filed in 2021 against several pharmaceutical companies. [...] …
New Medicaid Policy Change Could Reduce 340B Savings, Cause Drug Discontinuations, Warn Stakeholders
A Medicaid policy change that took effect at the start of 2024 could indirectly lead to lower 340B savings and [...] …
A key healthcare committee in the Iowa House of Representatives recently introduced a bill that would bar drug manufacturer restrictions [...] …
Pharmaceutical giant AbbVie recently urged a federal judge to rule on its suit against Louisiana’s 340B contract pharmacy law without [...] …
Two high-ranking West Virginia state senators recently introduced a bipartisan bill that would prohibit drug manufacturer restrictions on 340B contract [...] …
Drugmakers issued a record 41 refunds to 340B covered entities in 2023. And Merck is the first to announce it [...] …
Just days prior to implementing its first contract pharmacy restrictions, Japanese pharmaceutical giant Takeda yesterday announced it will increase the [...] …
Influential state senators in Kentucky, Virginia, and Florida have introduced bills recently that would prohibit drug manufacturer restrictions on 340B [...] …
Amid expected congressional gridlock, there is a much higher likelihood of state legislative action on 340B contract pharmacies than federal [...] …